| Name | Title | Contact Details |
|---|
Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates. These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending. Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™. The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee. Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema. Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.
Pet First Health Care is a Jeffersonville, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Quick Weight Loss Centers is a leading multi-state health and wellness company that provides highly differentiated weight loss management services. The company offers its program through both an in-center and digitally for clients not located in geographies with center locations.
SciMed LLC is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medisafe® is the leading Personalized Medication Management Platform helping patients stay on top of all their medications. Way more than a pill organizer (although it`s that, too), Medisafe makes it easy to adhere to the most complicated medication schedule, so wondering, “Did I take this already?” is a thing of the past. But that`s just the beginning. Medisafe connects users to their family (and soon, their doctors) for support, encouragement and expertise. It learns about each user`s unique situation, so it can deliver custom notifications for appointments and refills, medication updates, personalized health recommendations and discounts to help you stay organized, informed and on budget. And it tracks progress correlated with measurements like blood pressure and glucose levels to show the direct health benefit of taking meds as prescribed. By addressing all the major root causes for failing to take medications as prescribed, Medisafe improves patient satisfaction and quality of care and eliminates admissions and outpatient visits resulting from incorrect or missed doses. Medisafe arms providers and payers with information about patient compliance and related behaviors, so they can focus on the most pressing situations at any time. Understanding which patients are most at risk (and threatening to add avoidable strain to an overburdened healthcare system) helps all stakeholders in the care continuum use limited time and resources as efficiently as possible. Medisafe currently has more than 7 million users across iOS and Android smartphones and tablets, who have recorded over 4 billion medication doses taken correctly. Nearly 250,000 users have rated the app an average of 4.6 out of 5 stars in the iTunes and Google Play app stores.